Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03732820 |
|---|---|
| Brief Title: | Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer |
| First Submitted : | September 28, 2018 |
| First Submitted that Met QC Criteria : | November 5, 2018 |
| First Posted : | November 7, 2018 |
| Results First Submitted : | July 29, 2022 |
| Results First Posted with QC Comments : | August 26, 2022 |
| Results First Submitted that Met QC Criteria : | May 22, 2023 |
| Results First Posted : | June 15, 2023 |
| Last Update Submitted that Met QC Criteria : | February 2, 2024 |
| Last Update Posted : | February 28, 2024 |